000 | 01813 a2200577 4500 | ||
---|---|---|---|
005 | 20250513154411.0 | ||
264 | 0 | _c19981221 | |
008 | 199812s 0 0 eng d | ||
022 | _a0006-4971 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWoolfrey, A E | |
245 | 0 | 0 |
_aBone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome. _h[electronic resource] |
260 |
_bBlood _cNov 1998 |
||
300 |
_a3546-56 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
650 | 0 | 4 | _aCause of Death |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft vs Host Disease _xetiology |
650 | 0 | 4 |
_aGrowth Disorders _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aKarnofsky Performance Status |
650 | 0 | 4 |
_aLeukemia, Myeloid _xmortality |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyelodysplastic Syndromes _xmortality |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSalvage Therapy |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aTransplantation Conditioning _xadverse effects |
650 | 0 | 4 | _aTransplantation, Homologous |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aGooley, T A | |
700 | 1 | _aSievers, E L | |
700 | 1 | _aMilner, L A | |
700 | 1 | _aAndrews, R G | |
700 | 1 | _aWalters, M | |
700 | 1 | _aHoffmeister, P | |
700 | 1 | _aHansen, J A | |
700 | 1 | _aAnasetti, C | |
700 | 1 | _aBryant, E | |
700 | 1 | _aAppelbaum, F R | |
700 | 1 | _aSanders, J E | |
773 | 0 |
_tBlood _gvol. 92 _gno. 10 _gp. 3546-56 |
|
999 |
_c9772895 _d9772895 |